SCHEMBL20014643

SCHEMBL20014643

CN(C)c1ccc(CCN2C(=O)C=CC2=O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 4/20 0.60
GSK3B P49841 4/20 0.60
MGLL Q99685 6/20 0.59
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA4 P22748 1/20 0.54
CA9 Q16790 1/20 0.54
HSP90AA1 P07900 2/20 0.51
ALDH1A1 P00352 4/20 0.47
HPGD P15428 3/20 0.47
MAPT P10636 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
FAAH O00519 4/20 0.46
HRH3 Q9Y5N1 2/20 0.45
MAPK1 P28482 2/20 0.45
CYP3A4 P08684 1/20 0.45
TSHR P16473 1/20 0.45
TDP1 Q9NUW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19419960 0.79 GSK3A (0.66) GSK3AGSK3BMGLLCA1CA2
SCHEMBL4418547 0.78 CASP3 (0.59) CA1CA2CA4CA9ALDH1A1
SCHEMBL20251099 0.76 MGLL (0.66) GSK3AGSK3BMGLLCA1CA2
SCHEMBL7542262 0.76 MGLL (0.66) GSK3AGSK3BMGLLCA1CA2
SCHEMBL14677902 0.76 MGLL (0.66) GSK3AGSK3BMGLLCA1CA2
SCHEMBL23926407 0.76 MGLL (0.66) GSK3AGSK3BMGLLCA1CA2
SCHEMBL21291908 0.76 MGLL (0.66) GSK3AGSK3BMGLLCA1CA2
SCHEMBL3381344 0.75 GSK3A (1.00) GSK3AGSK3BMGLLCA1CA2
SCHEMBL211905 0.75 GSK3A (1.00) GSK3AGSK3BMGLLCA1CA2
SCHEMBL28234264 0.75 GSK3A (1.00) GSK3AGSK3BMGLLCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4275759-A2 QUINOLINE DERIVATIVES AS CHROMOBOX (CBX) PROTEIN INHIBITORS FOR TREATING CANCER Dana-Farber Cancer Institute, Inc. (US) 2023-11-15 EP disclosed
EP-3515449-B1 QUINOLINE DERIVATIVES AS CHROMOBOX (CBX) PROTEIN INHIBITORS FOR TREATING CANCER DANA FARBER CANCER INST INC (US) 2023-07-12 EP disclosed
WO-2018058029-A1 CHROMOBOX PROTEIN INHIBITORS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2018-03-29 WO disclosed